Aurigene Pharmaceutical Services Limited Opens State-of-the-Art Biologics Facility
Monday, 3 June 2024, 14:16
Aurigene Pharmaceutical Services Limited Biologics Facility Announcement
Aurigene Pharmaceutical Services Limited, a global Contract Research & Development Manufacturing Organization (CRDMO), has recently unveiled its latest venture - a new biologics facility offering cutting-edge process development and clinical scale manufacturing capabilities.
Main Highlights:
- State-of-the-art facility equipped for advanced biologics projects
- Supports innovative process development and clinical scale manufacturing
- Addresses the increasing demand for high-quality biologics services in the industry
By unveiling this new facility, Aurigene Pharmaceutical Services Limited aims to strengthen its position in the market and offer enhanced services to clients in need of comprehensive biologics solutions.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.